The study of protective efficacy to molecular target drug's dermatopathy by specialized amino acid supplement, Abound(TM)
Not Applicable
Recruiting
- Conditions
- liver cancer, colorectal cancer
- Registration Number
- JPRN-UMIN000014953
- Lead Sponsor
- Takasaki General Medical Center, National Hospital Organization
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
1)Child-Pugh grade B or C 2)Age is less than 20 years old. 3)The patients who judged a doctor to be inappropriate as an object of this study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method